NCT00778336

A Prospective Observational Registry of Peripheral Use of AngioJet Rheolytic Thrombectomy With Mid-Length Catheters

Peripheral Use of AngioJet Rheolytic Thrombectomy With Mid-Length Catheters

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 452 (actual)
• Sponsor: Boston Scientific Corporation · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This registry collects observational data about how mid-length AngioJet catheters (ie XPEEDIOR and DVX models) are used in routine clinical practice.

Detailed description

The PEARL Registry collects real world data about mid-length AngioJet catheters to: * Characterize usage patterns, treatment approaches, and targeted vessels * Document treatment strategies, including specific techniques and concomitant therapies * Collect outcome data during initial hospitalization and at a 3-month follow-up phone call or visit * Evaluate the frequency of specific clinical events in relation to risk factors, diagnosis, and treatments provided * Identify treatment strategies that may optimize procedural and clinical outcomes, to facilitate development of treatment guidelines * Offer sites a valuable resource for tracking usage and performance of the AngioJet System at their institution Information collected by the PEARL Registry is intended for educational and clinical research purposes only.

Conditions

• Peripheral Vascular Diseases
• Thrombosis
• Venous Thrombosis

Timeline

• Start date: 2007-01-01
• Primary completion: 2010-03-01
• Completion: 2010-04-01
• First posted: 2008-10-23
• Last updated: 2014-10-17
• Results posted: 2011-04-26